Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Purification and reconstitution of polyspecific H+/organic cation antiporter human MATE1.

Kawasaki T, Matsumoto T, Iwai Y, Kawakami M, Juge N, Omote H, Nabekura T, Moriyama Y.

Biochim Biophys Acta Biomembr. 2018 Jul 17. pii: S0005-2736(18)30200-1. doi: 10.1016/j.bbamem.2018.07.005. [Epub ahead of print]

PMID:
30028956
2.

Effects of Natural Polyphenols on the Expression of Drug Efflux Transporter P-Glycoprotein in Human Intestinal Cells.

Nabekura T, Kawasaki T, Furuta M, Kaneko T, Uwai Y.

ACS Omega. 2018 Feb 28;3(2):1621-1626. doi: 10.1021/acsomega.7b01679. Epub 2018 Feb 7.

3.

Crk Adaptor Proteins Regulate NK Cell Expansion and Differentiation during Mouse Cytomegalovirus Infection.

Nabekura T, Chen Z, Schroeder C, Park T, Vivier E, Lanier LL, Liu D.

J Immunol. 2018 May 15;200(10):3420-3428. doi: 10.4049/jimmunol.1701639. Epub 2018 Apr 4.

PMID:
29618525
4.

Nonlinear disposition of lithium in rats and saturation of its tubular reabsorption by the sodium-phosphate cotransporter as a cause.

Uwai Y, Kawasaki T, Nabekura T.

Biopharm Drug Dispos. 2018 Feb;39(2):83-87. doi: 10.1002/bdd.2116. Epub 2018 Jan 12.

PMID:
29214648
5.

Nitrogen Fixation Mutants of the Actinobacterium Frankia Casuarinae CcI3.

Kucho KI, Tamari D, Matsuyama S, Nabekura T, Tisa LS.

Microbes Environ. 2017 Dec 27;32(4):344-351. doi: 10.1264/jsme2.ME17099. Epub 2017 Nov 18.

6.

Proximal Gastrectomy with Double Tract Reconstruction Is an Alternative Revision Surgery for Intractable Complications After Sleeve Gastrectomy.

Oshiro T, Sato Y, Nabekura T, Kitahara T, Sato A, Kadoya K, Kawamitsu K, Takagi R, Nagashima M, Okazumi S, Katoh R.

Obes Surg. 2017 Dec;27(12):3333-3336. doi: 10.1007/s11695-017-2935-8.

PMID:
28965309
7.

Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection.

Nabekura T, Gotthardt D, Niizuma K, Trsan T, Jenus T, Jonjic S, Lanier LL.

J Immunol. 2017 Sep 1;199(5):1567-1571. doi: 10.4049/jimmunol.1700799. Epub 2017 Jul 31.

8.
9.

Effects of phenylpropanoids on human organic anion transporters hOAT1 and hOAT3.

Kawasaki T, Takeichi Y, Tomita M, Uwai Y, Epifano F, Fiorito S, Taddeo VA, Genovese S, Nabekura T.

Biochem Biophys Res Commun. 2017 Aug 5;489(4):375-380. doi: 10.1016/j.bbrc.2017.05.121. Epub 2017 May 27.

PMID:
28559139
10.

Enantioselective Effect of Flurbiprofen on Lithium Disposition in Rats.

Uwai Y, Matsumoto M, Kawasaki T, Nabekura T.

Pharmacology. 2017;99(5-6):236-239. doi: 10.1159/000455917. Epub 2017 Feb 2.

PMID:
28147361
11.
12.
13.

Foscarnet, an inhibitor of the sodium-phosphate cotransporter NaPi-IIa, inhibits phosphorylation of glycogen synthase kinase-3β by lithium in the rat kidney cortex.

Uwai Y, Kawasaki T, Nabekura T.

Drug Metab Pharmacokinet. 2016 Jun;31(3):256-9. doi: 10.1016/j.dmpk.2016.02.003. Epub 2016 Feb 26.

PMID:
27238574
14.
15.

Effects of Antiviral Drugs on Organic Anion Transport in Human Placental BeWo Cells.

Nabekura T, Kawasaki T, Kamiya Y, Uwai Y.

Antimicrob Agents Chemother. 2015 Dec;59(12):7666-70. doi: 10.1128/AAC.01634-15. Epub 2015 Sep 28.

16.

IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection.

Nabekura T, Girard JP, Lanier LL.

J Immunol. 2015 Jun 15;194(12):5948-52. doi: 10.4049/jimmunol.1500424. Epub 2015 Apr 29.

17.

Minor contribution of biliary excretion in lithium elimination in rats.

Uwai Y, Kawasaki T, Nabekura T.

Drug Metab Pers Ther. 2015 Mar;30(1):65-7. doi: 10.1515/dmdi-2014-0033.

PMID:
25803094
18.

Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein.

Nabekura T, Hiroi T, Kawasaki T, Uwai Y.

Biomed Pharmacother. 2015 Mar;70:140-5. doi: 10.1016/j.biopha.2015.01.007. Epub 2015 Jan 15.

PMID:
25776492
19.

Increased CD11b(+) Gr-1(+) cell population in the placenta after infection with Toxoplasma gondii.

Takeshima K, Sato K, Nabekura T, Nagamune K, Hamada H, Yoshikawa H, Shibuya A, Shibuya K.

Microbiol Immunol. 2015 Feb;59(2):95-8. doi: 10.1111/1348-0421.12225.

20.

Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation.

Nabekura T, Lanier LL.

J Exp Med. 2014 Nov 17;211(12):2455-65. doi: 10.1084/jem.20140798. Epub 2014 Nov 3.

21.

A case of cochlear implantation in a patient with Epstein syndrome.

Nabekura T, Nagano Y, Matsuda K, Tono T.

Auris Nasus Larynx. 2015 Apr;42(2):160-2. doi: 10.1016/j.anl.2014.09.004. Epub 2014 Oct 5.

PMID:
25293679
22.

Sodium-phosphate cotransporter mediates reabsorption of lithium in rat kidney.

Uwai Y, Arima R, Takatsu C, Furuta R, Kawasaki T, Nabekura T.

Pharmacol Res. 2014 Sep;87:94-8. doi: 10.1016/j.phrs.2014.06.012. Epub 2014 Jul 2.

PMID:
24997387
23.

PPARβ/δ activation of CD300a controls intestinal immunity.

Tanaka T, Tahara-Hanaoka S, Nabekura T, Ikeda K, Jiang S, Tsutsumi S, Inagaki T, Magoori K, Higurashi T, Takahashi H, Tachibana K, Tsurutani Y, Raza S, Anai M, Minami T, Wada Y, Yokote K, Doi T, Hamakubo T, Auwerx J, Gonzalez FJ, Nakajima A, Aburatani H, Naito M, Shibuya A, Kodama T, Sakai J.

Sci Rep. 2014 Jun 24;4:5412. doi: 10.1038/srep05412.

24.

Diuresis by intravenous administration of xanthurenic acid in rats, and inhibition by probenecid.

Uwai Y, Nakashima Y, Honjo E, Kawasaki T, Nabekura T.

Biomed Res. 2014;35(3):223-6.

25.

Effect of selective cyclooxygenase-2 inhibitor lumiracoxib on phenolsulfonphthalein disposition in rats.

Honjo H, Uwai Y, Nabekura T.

Drug Metabol Drug Interact. 2014;29(3):203-6. doi: 10.1515/dmdi-2014-0008.

PMID:
24870608
26.

Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection.

Nabekura T, Kanaya M, Shibuya A, Fu G, Gascoigne NR, Lanier LL.

Immunity. 2014 Feb 20;40(2):225-34. doi: 10.1016/j.immuni.2013.12.011. Epub 2014 Jan 16.

27.

Caffeic acid inhibits organic anion transporters OAT1 and OAT3 in rat kidney.

Uwai Y, Kawasaki T, Nabekura T.

Drug Metabol Drug Interact. 2013;28(4):247-50. doi: 10.1515/dmdi-2013-0050.

PMID:
24166669
28.

Elevation of plasma basic fibroblast growth factor after nocturnal hypoxic events in patients with obstructive sleep apnea syndrome.

Hirata Y, Nabekura T, Maruyama H, Aonuma K, Satoh M.

Springerplus. 2013 Jun 13;2(1):260. doi: 10.1186/2193-1801-2-260. Print 2013 Dec.

29.

Natural killer cells: walking three paths down memory lane.

Min-Oo G, Kamimura Y, Hendricks DW, Nabekura T, Lanier LL.

Trends Immunol. 2013 Jun;34(6):251-8. doi: 10.1016/j.it.2013.02.005. Epub 2013 Mar 14. Review.

30.

[Critical role of activating immune receptor DNAM-1 in the development of acute GVHD].

Kanaya M, Nabekura T, Shibuya K, Shibuya A.

Rinsho Ketsueki. 2012 May;53(5):497-503. Review. Japanese. No abstract available.

PMID:
22728551
31.

The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses.

Nakano-Yokomizo T, Tahara-Hanaoka S, Nakahashi-Oda C, Nabekura T, Tchao NK, Kadosaki M, Totsuka N, Kurita N, Nakamagoe K, Tamaoka A, Takai T, Yasui T, Kikutani H, Honda S, Shibuya K, Lanier LL, Shibuya A.

J Exp Med. 2011 Aug 1;208(8):1661-71. doi: 10.1084/jem.20101623. Epub 2011 Jul 4.

32.
33.

Critical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in mice.

Nabekura T, Shibuya K, Takenaka E, Kai H, Shibata K, Yamashita Y, Harada K, Tahara-Hanaoka S, Honda S, Shibuya A.

Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18593-8. doi: 10.1073/pnas.1005582107. Epub 2010 Oct 11.

34.

Overcoming multidrug resistance in human cancer cells by natural compounds.

Nabekura T.

Toxins (Basel). 2010 Jun;2(6):1207-24. doi: 10.3390/toxins2061207. Epub 2010 May 28. Review.

35.

Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals.

Nabekura T, Yamaki T, Hiroi T, Ueno K, Kitagawa S.

Pharmacol Res. 2010 Mar;61(3):259-63. doi: 10.1016/j.phrs.2009.11.010. Epub 2009 Nov 26.

PMID:
19944162
36.

The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells.

Fujisawa Y, Nabekura T, Nakao T, Nakamura Y, Takahashi T, Kawachi Y, Otsuka F, Onodera M.

Exp Dermatol. 2009 Apr;18(4):396-403. doi: 10.1111/j.1600-0625.2008.00802.x. Epub 2008 Oct 23.

PMID:
19054057
37.

Profiling gene expression in human placentae of different gestational ages: an OPRU Network and UW SCOR Study.

Mikheev AM, Nabekura T, Kaddoumi A, Bammler TK, Govindarajan R, Hebert MF, Unadkat JD.

Reprod Sci. 2008 Nov;15(9):866-77. doi: 10.1177/1933719108322425.

38.

Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1.

Nabekura T, Yamaki T, Kitagawa S.

Eur J Pharmacol. 2008 Dec 14;600(1-3):45-9. doi: 10.1016/j.ejphar.2008.10.025. Epub 2008 Oct 21.

PMID:
18955043
39.

Effects of plant sterols on human multidrug transporters ABCB1 and ABCC1.

Nabekura T, Yamaki T, Ueno K, Kitagawa S.

Biochem Biophys Res Commun. 2008 May 2;369(2):363-8. doi: 10.1016/j.bbrc.2008.02.026. Epub 2008 Feb 14.

PMID:
18280247
40.

Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals.

Nabekura T, Yamaki T, Ueno K, Kitagawa S.

Cancer Chemother Pharmacol. 2008 Oct;62(5):867-73. doi: 10.1007/s00280-007-0676-4. Epub 2008 Jan 19.

PMID:
18204840
41.

Effect of triterpenoids isolated from the floral spikes of Betula platyphylla var. japonica on P-glycoprotein function.

Sekiya M, Kashiwada Y, Nabekura T, Kitagawa S, Yamagishi T, Yokozawa T, Ichiyanagi T, Ikeshiro Y, Takaishi Y.

Planta Med. 2007 Dec;73(15):1558-62. Epub 2007 Dec 3.

PMID:
18058609
42.

Inhibitory effects of ginsenosides and their hydrolyzed metabolites on daunorubicin transport in KB-C2 cells.

Kitagawa S, Takahashi T, Nabekura T, Tachikawa E, Hasegawa H.

Biol Pharm Bull. 2007 Oct;30(10):1979-81.

43.

An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2.

Nabekura T, Nagasawa T, Nakauchi H, Onodera M.

Cancer Immunol Immunother. 2008 May;57(5):611-22. Epub 2007 Sep 5.

PMID:
17786440
44.

Inhibition of P-glycoprotein function by tannic acid and pentagalloylglucose.

Kitagawa S, Nabekura T, Nakamura Y, Takahashi T, Kashiwada Y.

J Pharm Pharmacol. 2007 Jul;59(7):965-9.

PMID:
17637191
45.

Enhanced skin permeation of diclofenac by ion-pair formation and further enhancement by microemulsion.

Kamal MA, Iimura N, Nabekura T, Kitagawa S.

Chem Pharm Bull (Tokyo). 2007 Mar;55(3):368-71.

46.

Stable transgene expression in mice generated from retrovirally transduced embryonic stem cells.

Hamanaka S, Nabekura T, Otsu M, Yoshida H, Nagata M, Usui J, Takahashi S, Nagasawa T, Nakauchi H, Onodera M.

Mol Ther. 2007 Mar;15(3):560-5. Epub 2006 Dec 19.

47.

Enhanced skin permeation of salicylate by ion-pair formation in non-aqueous vehicle and further enhancement by ethanol and l-menthol.

Abu Hena Mostofa Kamal M, Iimura N, Nabekura T, Kitagawa S.

Chem Pharm Bull (Tokyo). 2006 Apr;54(4):481-4.

48.

Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells.

Kitagawa S, Nabekura T, Takahashi T, Nakamura Y, Sakamoto H, Tano H, Hirai M, Tsukahara G.

Biol Pharm Bull. 2005 Dec;28(12):2274-8.

49.

Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap.

Nabekura T, Otsu M, Nagasawa T, Nakauchi H, Onodera M.

Mol Ther. 2006 Feb;13(2):301-9. Epub 2005 Nov 28.

50.

Effects of alkyl gallates on P-glycoprotein function.

Kitagawa S, Nabekura T, Kamiyama S, Takahashi T, Nakamura Y, Kashiwada Y, Ikeshiro Y.

Biochem Pharmacol. 2005 Oct 15;70(8):1262-6.

PMID:
16139251

Supplemental Content

Loading ...
Support Center